Khure Health

10/04/2022

We’re excited to introduce an innovative approach to physician continuing medical education (CME) that has the power to immediately impact patient care.

This evolution in CME delivery combines the AI-driven power of Khure’s clinical decision support platform with expert faculty-guided, College certified educational content such that physicians can, with the click of a button, conduct a full practice chart audit for the specific learning topic and surface patients potentially in need of clinical care pathway optimizations. Physicians can also efficiently develop and complete Quality Improvement Plans through the use of Khure’s advanced technology.

Learn more about how Primary Care Physicians can earn MainPro+ credits, and Specialists can earn Section3 Chart Audit and Assessment credits, increase your knowledge and foster better patient outcomes. Email andrews@khurehealth.ca

06/07/2022

Khure Health is excited to have our President, Don Watts, join the esteemed panel at the Canadian Organization for Rare Disorders (CORD) spring conference in Ottawa this week on “Canada’s SMART Rare Disease and Rare Drug System”, where he will discuss enhancing health care providers’ ability to recognize and diagnose rare conditions earlier with the support of AI-enabled clinical intelligence. For more information visit: bit.ly/3tk276u

Co-Panelists:
Dr. Pranesh Chakraborty, Newborn Screening
Dr. Kym Boycott, Genomic Sequencing
Orion Buske, PhenoTips

This two-day conference brings together the stakeholders and the learnings from all CORD and others’ consultations. We will collectively continue to bring in international expertise and benefit from global strategic thinking, innovative initiatives, and best practices. 

05/31/2022

Spotlight on: Dr. Fadie Amin, MD, Hon BSc, BHSc, AAFP, DABFM, CCFP
Khure Health Medical Advisor and Managing Partner, Family and Urgent Care Physician
St. Luke's Medical Centre, Toronto

"Using AI-enabled clinical intelligence to identify and treat rare diseases is very exciting and rewarding, in that it allows very busy primary care physicians the ability to change the lives of patients who for years often go unnoticed, and offers hope to immediately improve and often extend their lives. I have numerous examples in my own practice where Khure Health’s clinical decision support platform has helped me identify and diagnose patients with rare diseases.”

03/09/2022

As many primary care physicians know, it can be difficult to diagnose patients with rare diseases, especially as symptoms evolve over time and often mimic more common illnesses. A passionate supporter and user of the Khure Health platform, Dr. Nadia Alam explains that “decision-support tools like Khure Health don’t replace a clinical diagnosis, but they do make it more straightforward. A faster diagnosis means the world to patients and their families. It means the world to me because, finally, the pieces fit together and make sense.”

For more information on the Khure Health platform visit: https://khurehealth.ca/

03/03/2022

Newly developed AI-powered technologies such as Khure Health are playing a crucial role in enabling family doctors to spot the signs of rare diseases much earlier. Canada’s Rare Voices, via The Toronto Star, explores the promise and opportunities in the arrival of these technologies and what this means for Canadians living with rare and often poorly understood conditions, as well as every stakeholder in our health system. Read more here:
https://www.thestar.com/sponsored_sections/canada-s-rare-voices/2022/ai-driven-technologies-that-expedite-rare-disease-diagnoses-are-.html

Canadians living with rare — and often poorly understood — conditions see promise in the arrival of technologies that leverage GP-level health records to catch and identify stubborn diagnoses, like ADPKD. When these diseases are caught and treated early the outcome benefits not only the patient ...

03/01/2022

Don Watts, President of Khure Health, a subsidiary of MCI Onehealth, was featured on Digital Health Infocast discussing the implementation of AI technology for the timely diagnosis and treatment of rare diseases. Listen to the full podcast here: https://bit.ly/35mY7ZR

02/28/2022

February 28 is . A global movement dedicated to raising awareness for the 300 million people living with a rare disease. Khure Health proudly supports this movement working towards equity in healthcare and access to diagnosis for people living with a rare disease. Learn more at https://rarediseaseday.org

02/28/2022

Did you know that currently affect 5% of the worldwide population?
Khure Health is proud to raise awareness and help bring for those living with a rare disease. Visit the Rare Disease Day website for more information:https://rarediseaseday.org

02/14/2022

With 70% of genetic rare diseases starting in childhood, early diagnosis and treatment is key to improving outcomes and quality of life. Khure Health is proud to be a part of making a difference for patients and raising awareness for to generate change for everyone living with a rare disease, their families and carers. Learn more about how to show your support at: https://bit.ly/2CDgc28

02/02/2022

Did you know that undiagnosed and unmanaged Fabry Disease can reduce life expectancy by approximately 10 years in women and 20 years in men?

Caused by a mutation in the GLA gene, it causes buildup of fatty substance that narrows blood vessels and substantially raises the risk of heart attack, stroke and kidney failure.

Prevalence is difficult to determine and may be underestimated due to under diagnosis, but it is thought to affect between 1 and 5 out of 10,000 people.

Fabry disease is just one of the many rare diseases that the Khure Health platform can help doctors identify in their patients with the help of clinical intelligence.

02/01/2022

Khure Health supports rare disease awareness.

Rare Disease Day is on February 28, 2022.

12/24/2021

Check out Khure Health as featured in last weekend’s Health Insight insert in the The Toronto Star ! The Khure Health platform is enabling primary care physicians to rapidly screen and identify patients with rare and chronic diseases through its use of clinical data, machine learning and artificial intelligence.

In addition to bringing down average diagnosis time and facilitating more personalized treatment, Khure also utilizes its AI-enabled clinical intelligence platform to accelerate patient recruitment for clinical trials and speed scientific discovery.

Integrating tools such as the Khure Health platform into an easy-to-use interface to support physicians during the delivery of care is an important outcome of MCI Onehealth Technologies Inc. ! vision of personalized medicine.

The future of medicine will be personal.